As a leader in the treatment of cardiovascular diseases, Tampa General Hospital’s Heart and Vascular Institute created its Aorta Program to treat patients with all types of aortic diseases. The aorta is the largest blood vessel in the body and is the main conduit through which oxygenated blood travels from the heart to the rest of the body. Because the aorta is such an important structure in the circulatory system, any dysfunction in the artery—such as a blockage, compression or rupture—can lead to serious medical conditions.
As such, the Aorta Program team provides comprehensive diagnostic and treatment protocols to manage patients with even the most complex aortic conditions.
To schedule an appointment with the Heart and Vascular Institute, call 813-844-3900 or email firstname.lastname@example.org
What Sets Us Apart
Our team includes board-certified cardiac and vascular surgeons, anesthesiologists, vascular interventional radiologists, and many other medical experts. Our expertise allows us to diagnose and treat the most complex cases of aortic diseases. Learn more about the Aorta Program Team here.
Tampa General Hospital is a high-volume center for aortic procedures, treating over 100 abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA) cases combined and performing approximately 50 procedures involving the aortic root, ascending and transverse arch each year. These high volumes contribute to our ever-expanding expertise in treating all types of aortic diseases.
TGH doesn’t just practice medicine, we define it. This is evident in our commitment as a world-class academic hospital to provide our patients with the most technologically advanced procedures that make surgery safer and reduce recovery time and hospital stays.
For example, our vascular surgeons are national leaders in treating juxtarenal aortic aneurysms using the Cook Zenith® Fenestrated (Zfen) stent graft, a procedure that only six other hospitals in the nation have the technology to perform.
Because our goal is to always offer the most advanced open and endovascular techniques to manage all diseases of the aorta, TGH physicians are involved in numerous new device trials as well as medical management trials. In particular, we are part of studies evaluating the efficacy of doxycycline to prevent AAA growth in patients and the effectiveness of a new, low-profile device used to treat thoracoabdominal aortic aneurysm (TAAA).
Diseases We Treat
The aortic diseases treated at TGH include aortic aneurysms, aortic dissection, aortic ulcers and intramural hematomas and aortic occlusion.